Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2 breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2
PlexusDx Precision Peptide Genetic Test can identify whether your MC4R and GLP1R pathways suggest responsiveness to single-agent versus dual-compound strategies
During the quote process , you can adjust your deductible (from $0 to $10,000), choose your cost-share percentage, set a payment schedule, and pick modular add-ons
The OCLN fluorescence intensity was calculated as raw integrated density (Raw IntDen), which represents the sum of pixel intensity within each ROI, normalized by the number of nuclei
It will still have to go through Phase 3 clinical trials before FDA approval